spevigo
boehringer ingelheim international gmbh - spesolimab - psoriasis - immunosuppressiva - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
omvoh
eli lilly nederland b.v. - mirikizumab - colitis, ulcerativ - immunosuppressiva - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiske midler - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
cotellic
roche registration gmbh - cobimetinibhemifumarat - melanom - antineoplastiske midler - cotellic er indiceret til brug i kombination med vemurafenib til behandling af voksne patienter med uopløseligt eller metastatisk melanom med en braf v600 mutation.
aregen 1 % creme
mylan denmark aps - pimecrolimus - creme - 1 %
elidel 1 % creme
viatris aps - pimecrolimus - creme - 1 %
elidel 1 % creme
2care4 aps - pimecrolimus - creme - 1 %
elidel 1 % creme
orifarm a/s - pimecrolimus - creme - 1 %
elidel 10 mg/g creme
paranova danmark a/s - pimecrolimus - creme - 10 mg/g
fosrenol 1000 mg tyggetabletter
paranova danmark a/s - lanthanumcarbonathydrat - tyggetabletter - 1000 mg